10 Stocks Stand Strong Amid Cautious Market Environment

2. Hims & Hers Health, Inc. (NYSE:HIMS)

Telehealth company Hims & Hers Health, Inc. (NYSE:HIMS) saw its share prices increase by 17.5 percent on Wednesday to finish at $68.74 apiece as investors gobbled up shares following its recent move to expand into at-home blood testing and diagnostics.

On Wednesday, HIMS announced that it officially acquired at-home laboratory testing facility Trybe Labs, allowing the company to offer at-home blood draws and more comprehensive pretreatment testing.

HIMS did not disclose the terms of the deal but said the acquisition was completed through cash on hand.

“Access to richer data allows us to deepen the insights that providers can use on our platform to guide their clinical decisions for each individual patient,” HIMS Chief Medical Officer Dr. Patrick Carroll said. “At-home lab testing is one more exciting step towards elevating the personal, comprehensive care customers in this country should expect,” he added.